• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

磷脂分解代谢中间体甘油磷酸胆碱和甘油磷酸乙醇胺的水平在阿尔茨海默病患者的大脑中升高,但在唐氏综合征患者大脑中未升高。

Levels of phospholipid catabolic intermediates, glycerophosphocholine and glycerophosphoethanolamine, are elevated in brains of Alzheimer's disease but not of Down's syndrome patients.

作者信息

Blusztajn J K, Lopez Gonzalez-Coviella I, Logue M, Growdon J H, Wurtman R J

机构信息

Department of Pathology, Boston University School of Medicine, MA 02118.

出版信息

Brain Res. 1990 Dec 17;536(1-2):240-4. doi: 10.1016/0006-8993(90)90030-f.

DOI:10.1016/0006-8993(90)90030-f
PMID:2150771
Abstract

Concentrations of glycerophosphocholine and of glycerophosphoethanolamine, the metabolites of two major membrane phospholipid classes, phosphatidylcholine and phosphatidylethanolamine respectively, were determined post-mortem in cortical areas 20 and 40 and in cerebellum and caudate nucleus of brains obtained at autopsy from patients with Alzheimer's disease, Down's syndrome and age-matched control subjects. Glycerophosphocholine concentrations in all of the brain regions examined were higher by 67-150% in Alzheimer's disease than in control brains and 81-104% higher in Alzheimer's disease than in Down's syndrome. Glycerophosphoethanolamine concentrations were 21-52% higher in Alzheimer's disease than in controls, and 27-92% higher in Alzheimer's disease than Down's syndrome. Levels of glycerophosphocholine and of glycerophosphoethanolamine did not differ significantly between Down's syndrome and control brains. These data indicate that abnormal phospholipid metabolism in brain is characteristic of Alzheimer's disease but not Down's syndrome and suggest that this abnormality may be a central pathophysiological feature of Alzheimer's disease because levels of glycerophosphocholine and of glycerophosphoethanolamine are elevated in brain regions with and without manifestations of histopathology.

摘要

分别测定了磷脂酰胆碱和磷脂酰乙醇胺这两种主要膜磷脂类别的代谢产物甘油磷酸胆碱和甘油磷酸乙醇胺的浓度。这些样本来自于阿尔茨海默病患者、唐氏综合征患者以及年龄匹配的对照受试者的大脑,在尸检时获取大脑的皮质20区和40区、小脑以及尾状核。在所有检测的脑区中,阿尔茨海默病患者的甘油磷酸胆碱浓度比对照大脑高67%-150%,比唐氏综合征患者高81%-104%。阿尔茨海默病患者的甘油磷酸乙醇胺浓度比对照高21%-52%,比唐氏综合征患者高27%-92%。唐氏综合征患者和对照大脑之间的甘油磷酸胆碱和甘油磷酸乙醇胺水平没有显著差异。这些数据表明,大脑中异常的磷脂代谢是阿尔茨海默病的特征,而非唐氏综合征的特征,并且表明这种异常可能是阿尔茨海默病的一个核心病理生理特征,因为在有和没有组织病理学表现的脑区中甘油磷酸胆碱和甘油磷酸乙醇胺的水平都升高了。

相似文献

1
Levels of phospholipid catabolic intermediates, glycerophosphocholine and glycerophosphoethanolamine, are elevated in brains of Alzheimer's disease but not of Down's syndrome patients.磷脂分解代谢中间体甘油磷酸胆碱和甘油磷酸乙醇胺的水平在阿尔茨海默病患者的大脑中升高,但在唐氏综合征患者大脑中未升高。
Brain Res. 1990 Dec 17;536(1-2):240-4. doi: 10.1016/0006-8993(90)90030-f.
2
High brain myo-inositol levels in the predementia phase of Alzheimer's disease in adults with Down's syndrome: a 1H MRS study.唐氏综合征成年人患阿尔茨海默病痴呆前期脑肌醇水平升高:一项氢质子磁共振波谱研究
Am J Psychiatry. 1999 Dec;156(12):1879-86. doi: 10.1176/ajp.156.12.1879.
3
Regional brain 5-hydroxytryptamine levels are reduced in senile Down's syndrome as in Alzheimer's disease.与阿尔茨海默病一样,老年唐氏综合征患者大脑局部的5-羟色胺水平会降低。
Neurosci Lett. 1986 Apr 11;65(2):189-92. doi: 10.1016/0304-3940(86)90302-2.
4
Amyloid A4 protein and its precursor in Down's syndrome and Alzheimer's disease.唐氏综合征和阿尔茨海默病中的淀粉样蛋白A4及其前体
N Engl J Med. 1989 Jun 1;320(22):1446-52. doi: 10.1056/NEJM198906013202203.
5
Evidence for a membrane defect in Alzheimer disease brain.阿尔茨海默病大脑中存在膜缺陷的证据。
Proc Natl Acad Sci U S A. 1992 Mar 1;89(5):1671-5. doi: 10.1073/pnas.89.5.1671.
6
Low glucose metabolism during brain stimulation in older Down's syndrome subjects at risk for Alzheimer's disease prior to dementia.在患阿尔茨海默病风险较高的老年唐氏综合征患者出现痴呆之前,大脑刺激期间葡萄糖代谢较低。
Am J Psychiatry. 1997 Aug;154(8):1063-9. doi: 10.1176/ajp.154.8.1063.
7
Alterations of phospholipid metabolites in postmortem brain from patients with Alzheimer's disease.
Ann N Y Acad Sci. 1991;640:110-3. doi: 10.1111/j.1749-6632.1991.tb00200.x.
8
Loss of neurones from cortical and subcortical areas in Down's syndrome patients at middle age. Quantitative comparisons with younger Down's patients and patients with Alzheimer's disease.中年唐氏综合征患者皮质和皮质下区域神经元的丧失。与年轻唐氏患者及阿尔茨海默病患者的定量比较。
J Neurol Sci. 1987 Aug;80(1):79-89. doi: 10.1016/0022-510x(87)90223-1.
9
Nerve growth factor metabolic dysfunction in Down's syndrome brains.唐氏综合征大脑中的神经生长因子代谢功能障碍。
Brain. 2014 Mar;137(Pt 3):860-72. doi: 10.1093/brain/awt372. Epub 2014 Feb 11.
10
Age-related distribution of neuropathologic changes in the cerebral cortex of patients with Down's syndrome. Quantitative regional analysis and comparison with Alzheimer's disease.唐氏综合征患者大脑皮质神经病理改变的年龄相关分布。定量区域分析及与阿尔茨海默病的比较。
Arch Neurol. 1995 Apr;52(4):379-91. doi: 10.1001/archneur.1995.00540280065020.

引用本文的文献

1
Cellular and organismal function of choline metabolism.胆碱代谢的细胞与机体功能
Nat Metab. 2025 Jan;7(1):35-52. doi: 10.1038/s42255-024-01203-8. Epub 2025 Jan 8.
2
Cerebral Gray and White Matter Monogalactosyl Diglyceride Levels Rise with the Progression of Alzheimer's Disease.脑灰质和白质单半乳糖基二甘油酯水平随阿尔茨海默病的进展而升高。
J Alzheimers Dis. 2023;95(4):1623-1634. doi: 10.3233/JAD-230543.
3
Accelerated Breakdown of Phosphatidylcholine and Phosphatidylethanolamine Is a Predominant Brain Metabolic Defect in Alzheimer's Disease.
加速的磷脂酰胆碱和磷脂酰乙醇胺分解是阿尔茨海默病中主要的脑代谢缺陷。
J Alzheimers Dis. 2023;93(4):1285-1289. doi: 10.3233/JAD-230061.
4
Plasma Lipidomics Approach in Early and Specific Alzheimer's Disease Diagnosis.血浆脂质组学方法在早期和特异性阿尔茨海默病诊断中的应用
J Clin Med. 2022 Aug 27;11(17):5030. doi: 10.3390/jcm11175030.
5
Human Gray and White Matter Metabolomics to Differentiate APOE and Stage Dependent Changes in Alzheimer's Disease.利用人类灰质和白质代谢组学区分阿尔茨海默病中载脂蛋白E和阶段依赖性变化。
J Cell Immunol. 2021;3(6):397-412. doi: 10.33696/immunology.3.123.
6
Fat and Protein Combat Triggers Immunological Weapons of Innate and Adaptive Immune Systems to Launch Neuroinflammation in Parkinson's Disease.脂肪和蛋白质对抗先天和适应性免疫系统的触发因素,引发帕金森病的神经炎症。
Int J Mol Sci. 2022 Jan 19;23(3):1089. doi: 10.3390/ijms23031089.
7
disrupts intracellular lipid homeostasis in human iPSC-derived glia.扰乱了人诱导多能干细胞源性神经胶质细胞内的脂质内稳态。
Sci Transl Med. 2021 Mar 3;13(583). doi: 10.1126/scitranslmed.aaz4564.
8
Alkyl-Acylglycerols and the Important Clinical Ramifications of Raising Plasmalogens in Dementia and Alzheimer's Disease.烷基酰基甘油以及提高缩醛磷脂在痴呆症和阿尔茨海默病中的重要临床意义。
Integr Med (Encinitas). 2020 Jun;19(3):12-16.
9
Lipid class composition of membrane and raft fractions from brains of individuals with Alzheimer's disease.阿尔茨海默病患者大脑中膜和脂筏组分的脂质类别组成
Biochem Biophys Rep. 2019 Nov 4;20:100704. doi: 10.1016/j.bbrep.2019.100704. eCollection 2019 Dec.
10
B Vitamins and Fatty Acids: What Do They Share with Small Vessel Disease-Related Dementia?B 族维生素和脂肪酸:它们与小血管疾病相关痴呆有何关联?
Int J Mol Sci. 2019 Nov 18;20(22):5797. doi: 10.3390/ijms20225797.